Vivo Bio Tech Limited

Equities

VIVOBIOT6

INE380K01017

Biotechnology & Medical Research

Market Closed - Bombay S.E. 06:14:55 2024-05-23 am EDT 5-day change 1st Jan Change
40.85 INR -1.57% Intraday chart for Vivo Bio Tech Limited -2.53% +23.41%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Vivo Bio Tech Limited Reports Earnings Results for the Full Year Ended March 31, 2024 CI
Vivo Bio Tech Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024 CI
Vivo Bio Tech Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Vivo Bio Tech Limited Appoints Vaishnavi Kiran Ayinampudi as Company Secretary & Compliance Officer CI
Vivo Bio Tech Limited Announces the Resignation of Ms. Jyotika Aasat as Company Secretary & Compliance Officer of the Company with Effect from January 02, 2024 CI
Vivo Bio Tech Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
Vivo Bio Tech Limited Announces the Resignation of Hariharan Ravindran as Independent Director CI
Vivo Bio Tech Limited Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
Vivo Bio Tech Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023 CI
Vivo Bio Tech Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023 CI
Vivo Bio Tech Limited Announces Resignation of Sunder Kanaparthy as Independent Director, Effective from April 1, 2023 CI
Vivo Bio Tech Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022 CI
Vivo Bio Tech Limited announced a financing transaction CI
Vivo Bio Tech Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022 CI
Vivo Bio Tech Limited Announces Registered Office Address Changes CI
Vivo Bio Tech Limited Reports Earnings Results for the First Quarter Ended June 30, 2022 CI
Vivo Biotech Acquires Land in Telangana, India for $5 Million MT
Vivo Bio Tech Acquires Land and Building in Telangana, India for Nearly $5 Million MT
Vivo Bio Tech Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021 CI
Vivo Bio Tech to Set Up New Facility in Andhra Pradesh, India MT
Vivo Bio Tech Limited Executes a Lease Deed with M/S. Andhra Pradesh Med Tech Zone Limited for Setting Up a New Facility at Andhra Pradesh Med Tech Zone-Visakhapatnam CI
Vivo Bio Tech Limited Announces Change of Registered Office Address CI
Vivo Bio Tech Limited Announces Board Appointments CI
Vivo Bio Tech's CFO Tenders Resignation MT
Vivo Bio Tech Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021 CI
Chart Vivo Bio Tech Limited
More charts
Vivo Bio Tech Limited is a comprehensive pre-clinical clinical research organization (CRO) providing drug development and discovery services company. It operates in biotechnology segment. The Company offering drug development and discovery services to pharmaceutical and biotech companies. The Company offers services in the areas of in vivo and in vitro toxicity studies, pharmacological investigations, pharmacokinetic and toxic kinetic studies, genotoxicity screening, and analytical services. It provides both regulatory and non-regulatory IND enabling preclinical development services. The Company provides screening and evaluating molecules for various pharmacological and therapeutic properties. Specifically for oncology, it provides design and development of syngeneic / xenograft models for evaluation of anti-cancer agent. The Company also customizes In vivo drug metabolism and pharmacokinetics (DMPK) studies to help profile drug candidate in both rodent and non-rodent animal models.
More about the company
  1. Stock Market
  2. Equities
  3. VIVOBIOT6 Stock
  4. News Vivo Bio Tech Limited
  5. Vivo Bio Tech to Set Up New Facility in Andhra Pradesh, India